3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2004206812 (hide)

Owner Merck & Co. Inc.

Inventors Ashton, Wallace T.; Caldwell, Charles G.; Mathvink, Robert J.; Ok, Hyun O.; Reigle, Leah Bitalac; Weber, Ann E.

Agent Spruson & Ferguson

Pub. Number AU-A-2004206812

PCT Pub. Number WO2004/064778

Priority 60/440,732 17.01.03 US

Filing date 13 January 2004

Wipo publication date 5 August 2004

International Classifications

A61K 031/00

Event Publications

14 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064778 Priority application(s): WO2004/064778

28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206815-Branched vessel endoluminal device

2004206796-Geminally di-substituted NSAID derivatives as Abeta 42 lowering agents